Delivery Order SPE2DB20D9354-SPE2DB25FX7W2
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $6,087.32 to DMS Pharmaceutical Group Inc. for 300 tablets of Thiola EC 100 mg. The contract, issued on September 18, 2025, with an ultimate completion date of October 9, 2025, carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform the work at its facility in Park Ridge, IL 60068. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $6,087.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Thiola EC 100 mg tablets (300 count). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of June 24, 2025, and carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $6,370.06 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Thiola EC 100 mg tablets over a period ending on January 10, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group valued at $499,999,999, which allows the DLA to issue delivery orders for...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $6,370.06, is for the supply of THIOLA EC 100 MG TABLET 300S, a pharmaceutical product. This delivery order falls under DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA worth up to $499,999,999, which enables the DLA to issue firm fixed-price delivery orders...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,087.32 contract is for the delivery of Thiola EC 100 mg tablets and does not have a set-aside designation. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,370.06 firm fixed-price delivery order is for the supply of Thiola EC 100 mg tablets, a medication used to treat cystinuria. The award is part of a larger indefinite delivery/indefinite quantity (IDIQ) contract, SPE2DB, valued at up to $4,999,999, which enables DLA to issue delivery orders for a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,087.32 firm fixed-price delivery order is for the provision of 300 units of the prescription drug Thiola EC 100 mg tablets. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $6,087.32, is for the delivery of 4,567,721,073 units of Thiola EC 100 mg tablets. The contract does not have a set-aside designation and is valid through April 15, 2025. DMS Pharmaceutical Group Inc. also holds a single-award Indefinite Delivery Contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $12,740.12, is for the delivery of Thiola EC 100 mg tablets to DLA. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This single-award IDC, under the SPE2DB program,...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 100 mg Thiola EC tablets, with a ceiling value of $6,087.32 and a completion date of July 16, 2025. The contract is not set aside for any specific business category. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite...
- SPE2DB20D9354Indefinite Delivery Contract
- SPE2DB20D9354-SPE2DB25FX7W2Delivery Order
The Defense Logistics Agency (DLA) awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, a delivery order valued at $6,087.32 for 300 tablets of Thiola EC 100 mg on July 25, 2025. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, and will be performed in Park Ridge, Illinois. This award does not utilize a set-aside designation, allowing DMS Pharmaceutical Group to compete on a competitive basis leveraging its established position in federal pharmaceutical procurement. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA, valued at $499,999,999 and valid through November 2026. The underlying IDC, established under the DLA's SPE2DB program, enables the agency to procure a comprehensive range of pharmaceutical products, including prescription medications, over-the-counter items, biologics, and medical consumables to support the Department of Defense's healthcare facilities and military medical systems worldwide. Thiola, used in the treatment of cystinuria, represents one of the specialized pharmaceutical products within DMS Pharmaceutical Group's extensive delivery portfolio to federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.1k | 7/25/25 |